Publication | Closed Access
Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor‐21 in patients with type 2 diabetes and obesity
279
Citations
20
References
2008
Year
An increase in FGF21 levels after VLCD and fenofibrate treatment may contribute to positive metabolic effect of these interventions and suggests the possibility of direct positive metabolic effects of FGF21 in humans.
| Year | Citations | |
|---|---|---|
Page 1
Page 1